Pulse Biosciences (PLSE) Receivables - Other (2020 - 2021)

Name: Pulse Biosciences (PLSE) Receivables - Other (2020 - 2021) | Business Quant
Creator: Business Quant

Pulse Biosciences' quarterly Receivables - Other came in at $8.4 million in Q2 2021, up 584.46% quarter-over-quarter from $1.2 million in Q4 2020.

Pulse Biosciences has reported Receivables - Other for 2 years, with the latest figure at $8.4 million in Q2 2021.

For the quarter ending Q2 2021, Receivables - Other changed N/A year-over-year to $8.4 million; the trailing twelve-month figure through Jun 2021 stood at $8.4 million (changed N/A YoY), and the FY2020 full-year result was $1.2 million, changed N/A from the prior year.
Receivables - Other for Q2 2021 stood at $8.4 million, up from $1.2 million in the prior quarter.
The five-year high for Receivables - Other was $8.4 million in Q2 2021, with the low at $1.2 million in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn
10	Pulse Biosciences	1.72 Bn	1.72 Bn	-

Download Data 🔒